In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...

Sales results disclosed Tuesday raised concern that investors may have overestimated the demand for Zepbound and Mounjaro.

People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower ...

Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...

McDonald's shares underperformed in 2024, likely due to the rise of GLP-1 medications. Learn why MCD stock is a Sell.

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame ...